Recent Company News

• 04:04 AM ET Apr 30, 2026
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (92 total)

• 04:29 AM ET Apr 29, 2026
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (76 total)

• 09:31 PM ET Apr 24, 2026
  

  Sartorius Stedim Biotech upgraded to buy from hold at Intron Health (€162.30, 0.00)

• 08:00 AM ET Apr 23, 2026
  

  Transcript Intelligence: Sartorius Stedim Biotech Q1 Earnings Themes

• 08:00 AM ET Apr 23, 2026
  

  Transcript Intelligence: Sartorius Stedim Biotech Q1 Earnings Guidance

• 08:00 AM ET Apr 23, 2026
  

  Transcript Intelligence: Sartorius Stedim Biotech Q1 Earnings Q&A

• 04:30 AM ET Apr 23, 2026
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 02:59 AM ET Apr 23, 2026
  

  StreetAccount Summary - European pre-market trading update

• 01:17 AM ET Apr 23, 2026
  

  Sartorius Stedim Biotech reports Q1 underlying EPS €1.17 vs FactSet €1.21 [5 est, €1.19-1.22]; confirms F26 guidance (€184.00, 0.00)

• 11:40 PM ET Mar 29, 2026
  

  Sartorius Stedim Biotech upgraded to buy from neutral at Goldman Sachs (€165.00, 0.00)